PIONYR IMMUNOTHERAPEUTICS Trademark

Trademark Overview

On Friday, October 6, 2017, a trademark application was filed for PIONYR IMMUNOTHERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the PIONYR IMMUNOTHERAPEUTICS trademark a serial number of 87637095. The federal status of this trademark filing is REGISTERED as of Tuesday, September 28, 2021. This trademark is owned by PIONYR IMMUNOTHERAPEUTICS, INC.. The PIONYR IMMUNOTHERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of cancer
pionyr immunotherapeutics

General Information

Serial Number87637095
Word MarkPIONYR IMMUNOTHERAPEUTICS
Filing DateFriday, October 6, 2017
Status700 - REGISTERED
Status DateTuesday, September 28, 2021
Registration Number6502526
Registration DateTuesday, September 28, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 13, 2018

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of cancer
Disclaimer with Predetermined Text"IMMUNOTHERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 13, 2017
Primary Code005
First Use Anywhere DateMonday, May 3, 2021
First Use In Commerce DateMonday, May 3, 2021

Trademark Owner History

Party NamePIONYR IMMUNOTHERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NamePIONYR IMMUNOTHERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NamePIONYR IMMUNOTHERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94107

Trademark Events

Event DateEvent Description
Wednesday, January 3, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, January 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 28, 2021REGISTERED-PRINCIPAL REGISTER
Saturday, August 21, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, August 20, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 14, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 13, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 13, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 28, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 28, 2021NON-FINAL ACTION E-MAILED
Friday, May 28, 2021SU - NON-FINAL ACTION - WRITTEN
Friday, May 7, 2021STATEMENT OF USE PROCESSING COMPLETE
Tuesday, May 4, 2021USE AMENDMENT FILED
Tuesday, May 4, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, December 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 7, 2020SOU EXTENSION 5 GRANTED
Monday, November 2, 2020SOU EXTENSION 5 FILED
Monday, November 9, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 2, 2020SOU TEAS EXTENSION RECEIVED
Thursday, May 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 5, 2020SOU EXTENSION 4 GRANTED
Tuesday, May 5, 2020SOU EXTENSION 4 FILED
Tuesday, May 5, 2020SOU TEAS EXTENSION RECEIVED
Friday, October 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 16, 2019SOU EXTENSION 3 GRANTED
Wednesday, October 16, 2019SOU EXTENSION 3 FILED
Wednesday, October 16, 2019SOU TEAS EXTENSION RECEIVED
Friday, April 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 17, 2019SOU EXTENSION 2 GRANTED
Wednesday, April 17, 2019SOU EXTENSION 2 FILED
Wednesday, April 17, 2019SOU TEAS EXTENSION RECEIVED
Thursday, October 18, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 16, 2018SOU EXTENSION 1 GRANTED
Tuesday, October 16, 2018SOU EXTENSION 1 FILED
Tuesday, October 16, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, May 8, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 13, 2018PUBLISHED FOR OPPOSITION
Wednesday, February 21, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 23, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 23, 2018EXAMINER'S AMENDMENT ENTERED
Tuesday, January 23, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 23, 2018EXAMINERS AMENDMENT E-MAILED
Tuesday, January 23, 2018EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 16, 2018ASSIGNED TO EXAMINER
Friday, October 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 10, 2017NEW APPLICATION ENTERED

Related Keywords

immunotherapeutics pionyr cancer treatment pharmaceuticals